Published in Biomed Res Int on August 13, 2013
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound Healing. Genes (Basel) (2014) 0.86
Pentacyclic Triterpenoids Inhibit IKKβ Mediated Activation of NF-κB Pathway: In Silico and In Vitro Evidences. PLoS One (2015) 0.78
Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol (2016) 0.75
Mesenchymal Stem Cells as a Prospective Therapy for the Diabetic Foot. Stem Cells Int (2016) 0.75
Genome-Wide Association Identifies SLC2A9 and NLN Gene Regions as Associated with Entropion in Domestic Sheep. PLoS One (2015) 0.75
Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects. J Appl Oral Sci (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83
Macrophage activation and polarization. Front Biosci (2008) 11.17
Cellular and molecular basis of wound healing in diabetes. J Clin Invest (2007) 4.22
Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes (1974) 2.77
High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes (2008) 2.23
Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun (2005) 2.20
Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med (2011) 2.13
Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One (2010) 1.95
Neurotensin and neurotensin receptors. Trends Pharmacol Sci (1999) 1.71
Cytokines and macrophages. Biomed Pharmacother (1994) 1.60
Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int (2007) 1.54
Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes (2005) 1.50
Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res (2007) 1.47
Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br J Dermatol (2008) 1.39
Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med (2009) 1.22
Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? Cell Signal (2001) 1.20
Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. Am J Physiol Gastrointest Liver Physiol (2005) 1.16
Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol (2006) 1.16
Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci (2003) 1.08
Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Rev Diabet Stud (2006) 1.03
Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood) (2005) 1.00
Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. Diabetes (2005) 0.98
Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res (2009) 0.98
Mechanisms of regulation of neurotensin receptors. Pharmacol Ther (1998) 0.95
Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. Mol Pharmacol (2005) 0.94
Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line. J Neurosci Res (2004) 0.90
Substance P induces M2-type macrophages after spinal cord injury. Neuroreport (2012) 0.90
Motility pattern of isolated rat proximal colon and excitatory action of neurotensin. Eur J Pharmacol (1995) 0.89
Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother (2008) 0.89
Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem (1998) 0.89
G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia. Cell Biochem Biophys (2006) 0.85
Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue. Eur J Pharmacol (2011) 0.85
Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta (2011) 0.85
Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. Arch Immunol Ther Exp (Warsz) (2001) 0.84
Substance P augments nitric oxide production and gene expression in murine macrophages. Immunopharmacology (1999) 0.83
High glucose increases RAW 264.7 macrophages activation by lipoteichoic acid from Staphylococcus aureus. Clin Chim Acta (2008) 0.82
Neurotensin enhances nitric oxide generation via the JAK2-STAT1 pathway in murine macrophage Raw264.7 cells during costimulation with LPS and IFNgamma. Neuropeptides (2006) 0.81
Distribution, localization and characteristics of neurotensin binding sites in the rat brain. Neuropharmacology (1977) 0.81
Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy. Cell Tissue Res (2005) 0.80
Neuropeptides (SP and CGRP) augment pro-inflammatory cytokine production in HSV-infected macrophages. Int Immunopharmacol (2003) 0.80
Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Res (1993) 0.80
Activation of macrophages by neuropeptides. Brain Behav Immun (1988) 0.79
Stimulation of phagocytic function in mouse macrophages by neurotensin and neuromedin N. J Neuroimmunol (1993) 0.79
Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes (2012) 1.21
A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J (2003) 1.14
Essential oil of Daucus carota subsp. halophilus: composition, antifungal activity and cytotoxicity. J Ethnopharmacol (2008) 1.06
Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review. Acta Biomater (2013) 1.04
Propolis and its constituent caffeic acid suppress LPS-stimulated pro-inflammatory response by blocking NF-κB and MAPK activation in macrophages. J Ethnopharmacol (2013) 1.03
mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes. Mol Cell Endocrinol (2012) 1.02
Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells. PLoS One (2011) 0.98
Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity. PLoS One (2012) 0.97
The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Mol Cell Endocrinol (2012) 0.91
Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing. Expert Opin Biol Ther (2010) 0.90
Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol (2010) 0.90
Autophagy and inflammasome interplay. DNA Cell Biol (2015) 0.88
Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile. Mol Immunol (2009) 0.88
Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker. Cardiovasc Diabetol (2013) 0.87
Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. J Clin Endocrinol Metab (2014) 0.86
Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype. J Immunol (2013) 0.86
Cymbopogon citratus as source of new and safe anti-inflammatory drugs: bio-guided assay using lipopolysaccharide-stimulated macrophages. J Ethnopharmacol (2010) 0.86
Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta (2011) 0.85
Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds (2013) 0.84
Anti-inflammatory activity of Cymbopogon citratus leaf infusion in lipopolysaccharide-stimulated dendritic cells: contribution of the polyphenols. J Med Food (2010) 0.82
Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes. J Inorg Biochem (2009) 0.82
Three-dimensional human tissue models that incorporate diabetic foot ulcer-derived fibroblasts mimic in vivo features of chronic wounds. Tissue Eng Part C Methods (2015) 0.81
PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts. J Clin Invest (2016) 0.81
Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal neurons. J Neurochem (2004) 0.81
The effect of neurotensin in human keratinocytes--implication on impaired wound healing in diabetes. Exp Biol Med (Maywood) (2013) 0.80
Study of the antidiabetic capacity of the VO(dmpp)2 complex. J Inorg Biochem (2010) 0.80
Neurotensin-loaded collagen dressings reduce inflammation and improve wound healing in diabetic mice. Biochim Biophys Acta (2013) 0.80
Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line. Toxicol Lett (2007) 0.79
Neuronal nitric oxide synthase proteolysis limits the involvement of nitric oxide in kainate-induced neurotoxicity in hippocampal neurons. J Neurochem (2003) 0.78
Essential oils from Distichoselinum tenuifolium: chemical composition, cytotoxicity, antifungal and anti-inflammatory properties. J Ethnopharmacol (2010) 0.78
New compounds, chemical composition, antifungal activity and cytotoxicity of the essential oil from Myrtus nivellei Batt. & Trab., an endemic species of Central Sahara. J Ethnopharmacol (2013) 0.77
Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model. J Pharmacol Pharmacother (2012) 0.76
Elimination of glucose contamination from adipocyte glycogen extracts. Carbohydr Res (2008) 0.76
The sensitizers nickel sulfate and 2,4-dinitrofluorobenzene increase CD40 and IL-12 receptor expression in a fetal skin dendritic cell line. Biosci Rep (2004) 0.75
Effect of lipopolysaccharide, skin sensitizers and irritants on thioredoxin-1 expression in dendritic cells: relevance of different signalling pathways. Arch Dermatol Res (2009) 0.75
Signal transduction profile of chemical sensitisers in dendritic cells: an endpoint to be included in a cell-based in vitro alternative approach to hazard identification? Toxicol Appl Pharmacol (2010) 0.75
Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model. Ophthalmic Res (2017) 0.75
Antioxidant and anti-inflammatory activities of Geranium robertianum L. decoctions. Food Funct (2017) 0.75
Development of an in vitro dendritic cell-based test for skin sensitizer identification. Chem Res Toxicol (2013) 0.75